Bullous Pemphigoid: Symptoms, Diagnosis, and Treatment

Bullous pemphigoid is an autoimmune skin condition that often causes severe itching and firm, tense blisters. It most often affects older adults, and an itchy rash may appear before the blisters. This guide explains symptoms, diagnosis, treatment choices, skin care, and when to seek medical help.

Medical information: This guide is educational and cannot diagnose a blistering rash or replace medical care. New blisters or a persistent severe rash should be assessed by a clinician, especially before starting treatment.

Understanding the condition

Bullous pemphigoid (BP) is an autoimmune skin disease that causes inflammation, itching, and fluid-filled blisters. It most often affects older adults. Some people develop a prolonged itchy rash before the blisters appear; others have few or no visible blisters. The condition can range from a small localized area to widespread disease that needs close medical care.

The outer layer of skin is attached to a deeper layer by structures that include proteins such as BP180, also called type XVII collagen, and BP230. In bullous pemphigoid, the immune system makes antibodies against parts of this attachment system. Inflammation develops near the junction of the skin layers and fluid collects to form a tense blister. The exact reason this immune response begins is not always clear.

Bullous pemphigoid is not contagious and cannot be transmitted by touching another person. It is not caused by poor hygiene. Mouth or genital involvement can occur but is less common than skin disease. Treatment focuses on reducing inflammation and new blisters, protecting the skin, relieving itch, treating infection when present, and limiting medicine side effects.

Early itch and rash

Intense itch may be the first sign. It can begin weeks or months before a blister appears and may affect only a few areas or much of the body. The skin may look like eczema, hives, red or dusky patches, or small raised bumps. Because these early changes are nonspecific, bullous pemphigoid can be mistaken for another itchy rash.

Some people have a nonbullous form and never develop the classic large blisters. A persistent or severe itch in an older adult, especially with a new rash or skin thickening, deserves a medical assessment. The symptom alone does not identify BP: eczema, medication reactions, scabies, and many other conditions can also itch.

Blistering may develop after the itchy or hive-like phase, but not everyone follows the same sequence. The number of blisters can vary from a few to many. New crops may continue to appear while older areas collapse and heal. A record of when the itch began, when blisters started, and what medicines changed can help the clinician understand the pattern.

What the blisters look and feel like

BP typically produces firm, tense blisters filled with clear or sometimes blood-tinged fluid. They may arise on normal-looking skin or over an itchy rash. Because the roof is often stronger than the fragile blisters seen in pemphigus vulgaris, BP blisters may not rupture as easily. They can still break on their own, leaving raw or crusted areas that are tender.

Common locations include the lower abdomen, groin, armpits, inner arms and legs, and other flexural areas. The pattern may be localized or widespread across the trunk and limbs. The palms and soles can be affected in some forms. The mouth and other mucous membranes are less often involved; persistent mouth, eye, or genital symptoms should still be reported.

Color can vary with skin tone and with the stage of a lesion. In lighter skin, an active area may look red or pink; in darker skin, it may look dusky, brown, purple, or darker than nearby skin. Healing can leave temporary areas of lighter or darker pigment. Small white bumps called milia may appear in some healed sites. A skin photo can help track changes, but a visual comparison online is not a diagnosis.

Who is affected and what may be associated

Bullous pemphigoid becomes more common with age and usually begins in later adulthood. It is also seen in people living with neurological conditions such as stroke, dementia, Parkinson disease, epilepsy, or multiple sclerosis. This association does not mean that a neurological diagnosis causes BP or that every person with BP has a neurological condition.

Some prescription medicines have been associated with BP, including particular diabetes medicines and cancer immunotherapies. A reaction may begin months after a medicine was started and can sometimes arise after a medicine is stopped. These associations are uncommon, and many people taking these medicines never develop BP. Bring a full list of prescriptions, supplements, and recent changes to the appointment.

Do not discontinue a diabetes, cancer, or other prescription medicine on your own. A prescriber can decide whether it may be contributing, balance that possibility against the reason it was prescribed, and coordinate a safe substitute or adjustment if appropriate. People receiving cancer immunotherapy should tell their oncology team promptly about new severe itch, rash, or blisters.

Potential complications

Open blisters can allow bacteria or viruses to enter the skin. Warning signs include increasing pain, warmth, spreading redness, pus, or fever. Widespread disease can also interfere with sleep, movement, dressing, bathing, or other daily tasks. Older adults may be more vulnerable to dehydration, falls, or complications of other illnesses while a flare is active.

The illness and its treatment both matter. Oral corticosteroids can raise blood sugar and blood pressure, affect mood or sleep, weaken bones, and increase infection risk, especially when used at higher doses or over a long period. Other immune-modifying medicines have their own risks and monitoring needs. Clinicians try to control the disease while using the safest effective treatment for that person.

Severe widespread blistering, infection, inability to care for open areas at home, or difficulty keeping up with fluids and nutrition can require hospital treatment. An admission may provide wound support, pain control, monitoring, and treatment of complications while the dermatology team adjusts the plan. Hospital care is not required for everyone.

How bullous pemphigoid is diagnosed

Diagnosis starts with a history and examination. A dermatologist asks about the itch, rash, blisters, timing, medicines, prior skin conditions, and any mouth, eye, or genital symptoms. The clinician examines where the lesions are, whether blisters are tense or fragile, and whether signs of infection are present. A medication review is important, but the pattern alone rarely proves that a drug caused the condition.

A skin biopsy is commonly used to confirm suspected BP. A small sample from an early blister can show where the skin layers have separated. A second sample from skin close to a blister may be tested with direct immunofluorescence, which can show antibodies and complement deposited along the junction between skin layers. Correct site selection and specimen handling matter.

Blood tests may look for BP-related antibodies, including antibodies to BP180, and can support diagnosis or help monitor activity. They are interpreted together with examination and biopsy findings. A blood test is not a substitute for a full clinical evaluation, and a negative result may not answer every diagnostic question.

Several conditions can resemble BP, including eczema, drug eruptions, pemphigus vulgaris, dermatitis herpetiformis, and other autoimmune blistering disorders. If the appearance or test results are unclear, the dermatologist may request additional pathology or blood tests. The treatment plan should follow a confirmed diagnosis as closely as possible, particularly before starting medicines that suppress the immune system.

Treatment is tailored to health and disease extent

The treatment goal is to stop or reduce new blisters, heal open areas, relieve itch and pain, and prevent infection. A dermatologist chooses a plan based on affected body surface, disease activity, age, mobility, other medical conditions, current medicines, and the risks of treatment. The same medicine is not appropriate for everyone.

Topical corticosteroids applied to affected skin are a common treatment. A potent or very potent prescription product may be used over selected areas; the prescriber explains exactly where, how much, and how often to apply it. For a large area or more active disease, tablets such as oral corticosteroids may be considered. These medicines can work quickly but may have important side effects, so clinicians often aim to taper them as disease control allows.

Doxycycline or another anti-inflammatory medicine may be considered for selected people, including when the team wants to reduce exposure to oral steroids. Other medicines that modify immune activity may be considered for widespread disease or when corticosteroids cannot be used alone. Each choice has different risks, interactions, and monitoring requirements.

Dupilumab is approved by the U.S. Food and Drug Administration for adults with bullous pemphigoid. It is a biologic medicine that changes selected immune signals. A dermatologist may consider it for an appropriate adult patient, sometimes alongside a corticosteroid plan. Its availability and regulatory status can differ by country. Other biologic medicines may be considered in selected cases, but not all are approved specifically for BP in every location.

Before treatment, the care team may review vaccination status, infection history, blood pressure, blood sugar, bone health, and other conditions. During treatment, follow-up can include examination, blood tests, and checks for medication side effects. Do not abruptly stop an oral steroid or change the application schedule without discussing it with the prescriber.

Skin care and wound support

Open blisters and erosions need gentle care. A dermatologist may recommend how to clean the skin, which ointment or dressing to use, and how often to change it. Avoid adhesive dressings directly on fragile skin unless the clinician recommends them. Do not intentionally pop or drain blisters unless the dermatologist has shown you how and specifically advised it; opening a blister can increase infection risk.

Cool compresses may help relieve itch for some people. Keep nails short and try not to scratch, since scratching can break the skin. Loose, soft clothing can reduce friction. If a blister is on a foot, the care team may advise how to protect it and limit pressure until it settles. The appropriate dressing depends on the site and amount of drainage.

Hand hygiene matters when touching an open area or changing a dressing. Wash hands before and after wound care and use supplies as directed. Avoid sharing towels or dressings that have touched open skin. If there is worsening pain, warmth, redness, drainage, or fever, contact a clinician promptly rather than treating a possible infection with leftover medication.

Caregivers may help older adults with bathing, dressing, applying medicine, or changing dressings. Ask the clinician to demonstrate each step and provide written instructions. Also discuss fall prevention, comfortable sleep, and ways to manage itch without injuring the skin.

Daily comfort and practical planning

Severe itch can disrupt sleep and concentration. Ask the dermatologist which treatment or supportive measure is suitable rather than layering multiple over-the-counter creams. Some products can irritate or interact with prescribed care. Keeping a short symptom and treatment log can reveal whether itching, rash, and blisters are improving together.

Protect affected skin from rubbing, scratching, and unnecessary injury. If sunlight or heat worsens discomfort, use shade and comfortable clothing. Sunscreen can be applied to unaffected exposed skin, but avoid rubbing product into open sores unless the clinician has approved it. Tailor activity to the location of the blisters and any pain or mobility limits.

BP may affect self-confidence or mood, especially when visible lesions, sleep loss, or a long treatment course are involved. Tell the care team if itch or pain is making daily activities difficult or if treatment side effects are affecting quality of life. Support from family, caregivers, or a mental health professional can be part of good care.

Follow-up and outlook

Bullous pemphigoid can wax and wane. Some people have flares over months or years; others eventually enter a long-lasting remission and are able to stop treatment. A remission is a period when disease activity has settled; it does not always mean the condition can never return. The course depends on disease extent, associated health factors, and response to treatment.

Follow-up helps the dermatologist see whether new blisters are still forming, whether itch is improving, whether open areas are healing, and whether complications or medicine side effects have emerged. The treatment may be adjusted gradually. A reduced dose or maintenance plan can be safer than stopping abruptly, particularly after a long course of oral corticosteroids.

Write down the contact instructions for the dermatology team and primary care clinician. Ask how soon to report a new blister, what infection signs require urgent care, and which clinician to contact after hours. A coordinated plan is especially useful when a person has multiple chronic illnesses or takes several medicines.

When to seek medical care

Arrange a medical appointment for unexplained blisters, a persistent itchy rash that does not improve, or new skin fragility. Sudden blistering can have several causes, and an accurate diagnosis is essential before treatment. In an older adult, new severe itch with an eczema-like or hive-like rash should also be assessed.

Seek prompt advice for rapidly increasing blisters, widespread open skin, pain that prevents normal care, or signs of infection such as spreading redness, warmth, pus, or fever. Contact the treating clinician if eating, drinking, walking, or sleeping has become difficult. A person taking immune-modifying medicines should report possible infection early.

Urgent assessment is needed for severe eye pain, vision changes, extensive mouth or throat sores, difficulty swallowing, or breathing trouble. Call local emergency services for severe breathing difficulty, collapse, or another immediate emergency. Do not wait for a scheduled dermatology visit if a serious symptom is developing.

Questions to ask the dermatologist

Ask which findings support bullous pemphigoid, whether biopsy or blood testing is planned, and what other conditions have been considered. Ask how widespread the disease is, what counts as improvement, and how soon the treatment plan will be reviewed. If a medicine might be linked to the rash, ask the prescriber whether it should be changed and who will coordinate that decision.

Before starting a treatment, ask about the expected benefits, common and serious side effects, infection risk, interactions, and any monitoring tests. If you use an oral steroid, ask how it will be tapered and what to do if you miss a dose. For a biologic, ask about vaccination and infection precautions and how to contact the clinic after an injection.

Caregivers can ask how to protect fragile skin during bathing and dressing, which supplies to keep at home, and what signs suggest wound infection or dehydration. A written plan with medicine instructions, follow-up dates, and urgent contact details can make care easier to manage.

Key takeaways

Bullous pemphigoid is an autoimmune blistering disease that most often affects older adults. It can begin with severe itch or an eczema-like rash before firm blisters appear; some people never develop obvious blisters. Diagnosis commonly uses skin biopsy, direct immunofluorescence, and sometimes blood antibody tests. Treatment is individualized and may include corticosteroids, other immune-modifying medicines, or biologics such as dupilumab for eligible adults in the United States. Gentle wound care and regular follow-up help manage complications and medication risks.

Frequently asked questions

Sources and further reading

These dermatology and public-health resources informed this overview. A dermatologist can interpret symptoms and test results for an individual case.

• DermNet: Bullous pemphigoid
• American Academy of Dermatology: Bullous pemphigoid signs and symptoms
• AAD: Bullous pemphigoid diagnosis and treatment
• AAD: Bullous pemphigoid self-care
• MedlinePlus Medical Encyclopedia: Bullous pemphigoid

Editorial note: Dupilumab is FDA-approved for adults with bullous pemphigoid in the United States; eligibility, availability, and treatment standards vary by location. Use medication only under the care of a qualified clinician.